Matthew J Pfeffer's Net Worth
$5.65 Million
Who is Matthew J Pfeffer?
Matthew J Pfeffer has an estimated net worth of $5.65 Million. This is based on reported shares across multiple companies, which include Divine Skin Inc., MANNKIND CORP, SECOND SIGHT MEDICAL PRODUCTS INC, VAXGEN INC, GENELABS TECHNOLOGIES INC /CA, and CELL GENESYS INC.
SEC CIK
Matthew J Pfeffer's CIK is 0001192063
Past Insider Trading and Trends
2014 was Matthew J Pfeffer's most active year for acquiring shares with 12 total transactions. Matthew J Pfeffer's most active month to acquire stocks was the month of July. 2014 was Matthew J Pfeffer's most active year for disposing of shares, totalling 10 transactions. Matthew J Pfeffer's most active month to dispose stocks was the month of July. 2016 saw Matthew J Pfeffer paying a total of $1,887,248.78 for 1,992,028 shares, this is the most they've acquired in one year. In 2014 Matthew J Pfeffer cashed out on 281,559 shares for a total of $2,543,561.67, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DS HEALTHCARE GROUP, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Feb 5
| |||
Form 4/A
|
∞
| 5K |
—
|
—
| 5K |
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MANNKIND CORP (MNKD) Snapshot price: $5.85
CEO, CFO, Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.37% | -303.00 |
$1.55 | -$469.65 | 81.96K |
Aug 28
| |||
Form 4
| +2.04% | 1.65K |
$1.34 | $1,953.12 | 82.26K |
Jun 30 - Aug 22
| |||
Form 4
| +1.14% | 4.54K |
$0.54 | $2,451.60 | 403.08K |
Jan 3
| |||
Form 4
| +6.70% | 25K |
$0.99 | $24,650.00 | 398K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +3.08% | 11.15K |
$4.00 | -$19,830.34 | 373K |
Aug 16 - Aug 27
| |||
Form 4
| +2.56% | 9.03K |
$6.43 | -$38,419.25 | 361.85K |
Feb 3 - Feb 23
| |||
Form 4
| +43.71% | 113.73K |
$8.52 | -$987,540.63 | 373.93K |
Aug 11 - Aug 22
| |||
Form 4
| -2.49% | -6.13K |
$6.96 | -$42,693.04 | 240.2K |
Aug 16 - Aug 19
| |||
Form 4
| +20.19% | 119.54K |
$10.00 | -$1,094,560.00 | 711.57K |
Oct 14 - Jun 27
| |||
Form 4
| -13.63% | -20.00K |
$10.44 | -$208,768.00 | 126.78K |
Jul 1
| |||
Form 4
| +0.36% | 527 |
$4.42 | $2,329.34 | 146.78K |
Jun 30
| |||
Form 4
| -6.40% | -10.00K |
$6.37 | -$187,700.00 | 146.26K |
Jun 4 - Jun 5
| |||
Form 4
| +0.31% | 487 |
$4.53 | $2,206.11 | 156.26K |
Dec 31
| |||
Form 4
| +78.82% | 68.66K |
$4.88 | -$201,729.44 | 155.77K |
Nov 21
| |||
Form 4
| +11.52% | 9K |
—
|
—
| 87.11K |
Aug 22
| |||
Form 4
| -6.63% | -5.55K |
$6.02 | -$33,390.68 | 78.11K |
Aug 16 - Aug 19
| |||
Form 4
|
—
|
0
|
$5.43 | -$51,400.00 | 83.65K |
Aug 1
| |||
Form 4
| -10.68% | -10.00K |
$7.00 | -$70,000.00 | 83.65K |
Jul 2
| |||
Form 4
| +8.64% | 7.45K |
$1.96 | $14,598.08 | 93.65K |
Jun 30
| |||
Form 4
| -10.39% | -10.00K |
$5.00 | -$50,000.00 | 86.21K |
May 15
| |||
Form 4
| +1.11% | 1.06K |
$1.95 | $2,059.20 | 96.21K |
Dec 31
| |||
Form 4
| +21.75% | 17K |
—
|
—
| 95.15K |
Aug 16
| |||
Form 4
| +1.37% | 1.05K |
$1.95 | $2,055.30 | 78.15K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +28.73% | 17K |
—
|
—
| 76.17K |
Aug 18
| |||
Form 4
| +36.02% | 15.5K |
—
|
—
| 58.53K |
Mar 3
| |||
Form 4
|
—
|
0
|
$6.43 | -$44,982.00 | 43.03K |
Jan 18
| |||
Form 4
| +38.59% | 11.9K |
$5.97 | -$6,572.97 | 42.73K |
Aug 19
| |||
Form 4/A
|
—
|
0
|
$6.43 | -$44,982.00 | 28.86K |
May 18 - Feb 17
| |||
Form 4
|
—
|
0
|
$5.72 | -$53,928.00 | 28.86K |
May 18 - Feb 17
| |||
Form 4/A
| +15.42% | 3.85K |
$5.83 | -$12,505.35 | 28.86K |
May 18
| |||
Form 4
| +71.19% | 12K |
—
|
—
| 28.86K |
Aug 19
| |||
Form 4
| +48.61% | 3.85K |
—
|
—
| 11.79K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
|
∞
| 4.5K |
—
|
—
| 4.5K |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SECOND SIGHT MEDICAL PRODUCTS INC (VANI) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +42.93% | 35.53K |
—
|
—
| 118.3K |
Jun 1 - Jun 2
| |||
Form 4
| +259.19% | 59.73K |
$1.17 | $69,997.70 | 82.77K |
Jun 1
| |||
Form 4
| +31.97% | 5.58K |
$1.47 | $8,205.54 | 23.04K |
Mar 14
| |||
Form 4
|
∞
| 17.46K |
$3.95 | $68,997.14 | 17.46K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VAXGEN INC No price found
SENIOR VICE PRESIDENT AND CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 10K |
$0.46 | $4,600.00 | 20K |
Dec 4
| |||
Form 4
|
∞
| 10K |
$0.60 | $6,000.00 | 10K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GENELABS TECHNOLOGIES INC /CA No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
$1.30 | -$13,000.00 |
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |